Canaria Bio Acquires 11 Billion KRW Convertible Bonds Before Maturity
[Asia Economy Reporter Lee Jung-yoon] Canaria Bio announced on the 22nd that it has decided to acquire anonymously issued, non-guaranteed private convertible bonds (CB) with detachable warrants worth 1,102,834,000 KRW before maturity.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [Weather] Nationwide Rain Brings Relief from Heat... Up to 80mm or More Expected
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The conversion price per share is 28,144 KRW, and the reason for acquisition before maturity is the bondholder's exercise of the early redemption right. Decisions regarding resale or cancellation will be made at a future board meeting.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.